Profile
SONN VRTX VRNA REGN ALNY ARGX
Company Name Sonnet BioTherapeutics Holdings, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $21.42M $108.04B $72.68B $67.32B $58.93B $50.86B
Employees 0.01K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Raghu Rao Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
SONN VRTX VRNA REGN ALNY ARGX
Quant Rating Score 2 3 1 4 2 4
Quant Rating Sell Neutral Strong Sell Buy Sell Buy
Trading
SONN VRTX VRNA REGN ALNY ARGX
Last Close $4.55 $417 $106.91 $644.19 $434.56 $832.35
High 52 $9.77 $516.74 $106.91 $828.42 $491.09 $849.46
Low 52 $1.11 $366.54 $35.37 $482.92 $224.58 $532.27
Price vs. 52 Week High -53.43 % -19.3 % 0 % -22.24 % -11.51 % -2.01 %
Price vs. 52 Week Low 309.91 % 13.77 % 202.26 % 33.39 % 93.5 % 56.38 %
Total Return
SONN VRTX VRNA REGN ALNY ARGX
1 Month Return -16.36 % 3.5 % 0 % 10.13 % -3.86 % 5.51 %
3 Month Return 51.41 % 8.13 % 1.44 % 16.04 % 1.52 % 23.73 %
6 Month Return 244.7 % -7.34 % 52.58 % 15.34 % 61.06 % 35.28 %
9 Month Return 180.86 % -13.33 % 74.55 % -10.79 % 56.18 % 26.5 %
YTD Return 211.64 % 3.55 % 130.21 % -9.57 % 84.68 % 35.34 %
1 Year Return 21.98 % -15.53 % 184.41 % -21.12 % 59.17 % 41.32 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SONN VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.41 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -147.93 % 4.25 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
SONN VRTX VRNA REGN ALNY ARGX
Asset Growth -48.96 % 53.91 %
Gross Profit Growth -87.4 % 5941.02 %
Revenue Growth -87.4 % -
Revenue 3 Year -99.94 % -23.33 %
Revenue 5 Year -100 % 290254.46 %
Revenue 10 Year - -
EBIT Growth 36.95 % -162.64 %
Net Income Growth 60.51 % -218.96 %
Net Income 3 Yeari Growth Per Share 99.55 % -126.38 %
Net Income 5 Yeari Growth Per Share 99.97 % 33.14 %
Net Income 10 Yeari Growth Per Share - -7.28 %
Operating Income Growth 36.95 % -127.96 %
Operating Cash Flow Growth (CFG) 59.67 % -143.33 %
Operating 3 Year CFG 99.42 % -166.57 %
Operating 5 Year CFG 99.94 % 55.51 %
Operating 10 Year CFG 99.99 % 41.1 %
EPS Growth 92.18 % -200 %
EPS Diluted Growth 92.18 % -215.05 %
Book Value Per Share 57.43 % -24.01 %
Share Holder 3 Year Equity Growth Per Share -100.03 % 0.26 %
Share Holder 5 Year Equity Growth Per Share 100 % -25.62 %
Share Holder 10 Year Equity Growth Per Share - -72.3 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -35.82 % 139.05 %
Free Cash Flow Growth 60.49 % -144.48 %
Updated On 30 Sep 2024 31 Dec 2024
Profitability
SONN VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM -95.19 % 86.11 % 95.15 % 85.39 % 51.22 % 65.82 %
Return on Assets TTM -659.56 % 15.13 % -14.17 % 11.4 % 0.9 % 15.06 %
Return on Equity TTM -4648.06 % 22.14 % -38.66 % 15.31 % 26.13 % 18.96 %
Return on Capital Employed TTM 461.47 % 19.72 % -10.74 % 10.32 % 8.03 % 5.04 %
Net Income Per EBT TTM 101.18 % 83.16 % 111.3 % 88.98 % -136.38 % 237.3 %
EBT Per Ebit TTM 95.3 % 111.48 % 130.22 % 139.5 % -12.07 % 147.38 %
EBIT Per Revenue TTM -1405.87 % 34.36 % -25.27 % 25.89 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM -14978.45 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Receivables Turnover TTM 1.67 6.03 2.55 2.51 3.33 1.91
Payables Turnover TTM 0.02 3.59 3.13 2.3 2.69 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 4.2 2.26
Fixed Asset Turnover TTM 1290.42 % 431.08 % 8642.22 % 284.82 % 463.12 % 5009.77 %
Asset Turnover TTM 48.65 % 47.51 % 38.7 % 35.47 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -2.6 14.98 -0.85 48.94 2.02 5.67
Free Cash Flow Per Share TTM -2.6 13.63 -0.85 40.09 1.68 5.58
Cash Per Share TTM 8.1 % 2486.48 % 511.44 % 8148.65 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -1031.07 % 33.68 % -32.7 % 35.59 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 100.75 % 81.92 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM -14978.45 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Price To Free Cash Flows Ratio TTM -2.08 30.87 -995.27 16.2 266.2 127.08
Price To Operating Cash Flows Ratio TTM -1.23 28.12 -126.33 13.32 222.27 145.15
Price Cash Flow Ratio TTM -1.23 28.12 -126.33 13.32 222.27 145.15
Income Statement (TTM)
SONN VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.01B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -11.35 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
SONN VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $2.59B $0.03B
Total Liabilities $0B $6.12B $0.27B $8.41B $4.23B $0.7B
Total Equity $-0B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.8B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $2.74B $0.04B
Total Assets $0B $22.53B $0.47B $37.76B $4.3B $6.2B
Cash Flow Statement (TTM)
SONN VRTX VRNA REGN ALNY ARGX
Net Income $-0.01B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 32.625
AARD Aardvark Therapeutics, Inc. Common Stock 9.82
ABCL AbCellera Biologics Inc. 4.525
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.9
ABPWW 0.0173
ABSI Absci Corporation 3.585
ABUS Arbutus Biopharma Corporation 4.465
ABVC ABVC BioPharma, Inc. 2.85
ABVX Abivax SA American Depositary Shares 103.99
ACAD ACADIA Pharmaceuticals Inc. 21.665
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6702
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.72
ACIU AC Immune SA 3.4375
ETFs With Exposure to SONN
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.095
VXF Vanguard Extended Market Index Fund 0.00034 205.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00034 158.75
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00034 158.76
VEMPX Vanguard Extended Market Index InstlPlus 0.00034 391.76
Unlock